nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Keratosis pilaris—Vemurafenib—melanoma	0.143	0.241	CcSEcCtD
Fluocinolone Acetonide—Wound dehiscence—Carmustine—melanoma	0.0314	0.053	CcSEcCtD
Fluocinolone Acetonide—Wound—Carmustine—melanoma	0.0249	0.0421	CcSEcCtD
Fluocinolone Acetonide—Condition aggravated—Temozolomide—melanoma	0.0191	0.0323	CcSEcCtD
Fluocinolone Acetonide—Rash papular—Vemurafenib—melanoma	0.0184	0.031	CcSEcCtD
Fluocinolone Acetonide—Skin striae—Bleomycin—melanoma	0.013	0.022	CcSEcCtD
Fluocinolone Acetonide—Conjunctival oedema—Carmustine—melanoma	0.013	0.022	CcSEcCtD
Fluocinolone Acetonide—Retinal haemorrhage—Carmustine—melanoma	0.0111	0.0187	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Vemurafenib—melanoma	0.0109	0.0184	CcSEcCtD
Fluocinolone Acetonide—Impaired healing—Carmustine—melanoma	0.00836	0.0141	CcSEcCtD
Fluocinolone Acetonide—Photopsia—Docetaxel—melanoma	0.00731	0.0123	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Bleomycin—melanoma	0.00697	0.0118	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Dactinomycin—melanoma	0.00615	0.0104	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Carmustine—melanoma	0.00608	0.0103	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Temozolomide—melanoma	0.00588	0.00992	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Vemurafenib—melanoma	0.00497	0.00838	CcSEcCtD
Fluocinolone Acetonide—Abscess—Carmustine—melanoma	0.00457	0.00772	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Temozolomide—melanoma	0.00449	0.00758	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Bleomycin—melanoma	0.00402	0.00679	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Docetaxel—melanoma	0.00395	0.00667	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Docetaxel—melanoma	0.00391	0.0066	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Temozolomide—melanoma	0.00387	0.00653	CcSEcCtD
Fluocinolone Acetonide—Infestation—Vemurafenib—melanoma	0.00383	0.00646	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Vemurafenib—melanoma	0.00383	0.00646	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Temozolomide—melanoma	0.00379	0.0064	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Carmustine—melanoma	0.00366	0.00618	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Vemurafenib—melanoma	0.00338	0.0057	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Temozolomide—melanoma	0.00323	0.00545	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Vemurafenib—melanoma	0.00321	0.00542	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Vemurafenib—melanoma	0.0031	0.00523	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Vemurafenib—melanoma	0.00304	0.00512	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Vemurafenib—melanoma	0.00299	0.00505	CcSEcCtD
Fluocinolone Acetonide—Erythema—Vemurafenib—melanoma	0.00299	0.00505	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Docetaxel—melanoma	0.00299	0.00504	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Temozolomide—melanoma	0.00297	0.00502	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Vemurafenib—melanoma	0.00293	0.00494	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Carmustine—melanoma	0.00291	0.00491	CcSEcCtD
Fluocinolone Acetonide—Back pain—Vemurafenib—melanoma	0.00289	0.00488	CcSEcCtD
Fluocinolone Acetonide—Rhinorrhoea—Docetaxel—melanoma	0.00287	0.00484	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Temozolomide—melanoma	0.00286	0.00483	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Temozolomide—melanoma	0.00281	0.00475	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Docetaxel—melanoma	0.00272	0.0046	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Carmustine—melanoma	0.00263	0.00443	CcSEcCtD
Fluocinolone Acetonide—Cough—Vemurafenib—melanoma	0.00261	0.0044	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Vemurafenib—melanoma	0.00255	0.0043	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Temozolomide—melanoma	0.00254	0.00428	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Docetaxel—melanoma	0.00252	0.00426	CcSEcCtD
Fluocinolone Acetonide—Infection—Vemurafenib—melanoma	0.00242	0.00409	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Vemurafenib—melanoma	0.00239	0.00404	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00222	0.00375	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00211	0.00356	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Temozolomide—melanoma	0.00204	0.00344	CcSEcCtD
Fluocinolone Acetonide—Infestation—Temozolomide—melanoma	0.00196	0.0033	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Temozolomide—melanoma	0.00196	0.0033	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Vemurafenib—melanoma	0.00193	0.00326	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Bleomycin—melanoma	0.00184	0.0031	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Temozolomide—melanoma	0.00183	0.0031	CcSEcCtD
Fluocinolone Acetonide—Erythema—Bleomycin—melanoma	0.00181	0.00306	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vemurafenib—melanoma	0.0018	0.00304	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Carmustine—melanoma	0.00179	0.00301	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Docetaxel—melanoma	0.00178	0.00301	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Carmustine—melanoma	0.00175	0.00296	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vemurafenib—melanoma	0.00173	0.00291	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Temozolomide—melanoma	0.00173	0.00291	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Dactinomycin—melanoma	0.00172	0.0029	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Carmustine—melanoma	0.0017	0.00287	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Temozolomide—melanoma	0.00169	0.00286	CcSEcCtD
Fluocinolone Acetonide—Erythema—Dactinomycin—melanoma	0.00169	0.00285	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Docetaxel—melanoma	0.00169	0.00285	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vemurafenib—melanoma	0.00167	0.00282	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Temozolomide—melanoma	0.00164	0.00277	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vemurafenib—melanoma	0.00161	0.00272	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Carmustine—melanoma	0.00161	0.00271	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Carmustine—melanoma	0.00159	0.00269	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Temozolomide—melanoma	0.00158	0.00267	CcSEcCtD
Fluocinolone Acetonide—Erythema—Carmustine—melanoma	0.00158	0.00267	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Carmustine—melanoma	0.00158	0.00267	CcSEcCtD
Fluocinolone Acetonide—Cough—Bleomycin—melanoma	0.00158	0.00267	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vemurafenib—melanoma	0.00155	0.00262	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Temozolomide—melanoma	0.00155	0.00262	CcSEcCtD
Fluocinolone Acetonide—Rash—Vemurafenib—melanoma	0.00154	0.0026	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Temozolomide—melanoma	0.00154	0.0026	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vemurafenib—melanoma	0.00154	0.0026	CcSEcCtD
Fluocinolone Acetonide—Back pain—Carmustine—melanoma	0.00153	0.00258	CcSEcCtD
Fluocinolone Acetonide—Headache—Vemurafenib—melanoma	0.00153	0.00258	CcSEcCtD
Fluocinolone Acetonide—Erythema—Temozolomide—melanoma	0.00153	0.00258	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Temozolomide—melanoma	0.00153	0.00258	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Docetaxel—melanoma	0.00151	0.00255	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Temozolomide—melanoma	0.0015	0.00253	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Carmustine—melanoma	0.00149	0.00252	CcSEcCtD
Fluocinolone Acetonide—Oedema—Bleomycin—melanoma	0.00148	0.0025	CcSEcCtD
Fluocinolone Acetonide—Back pain—Temozolomide—melanoma	0.00148	0.0025	CcSEcCtD
Fluocinolone Acetonide—Infection—Bleomycin—melanoma	0.00147	0.00248	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vemurafenib—melanoma	0.00145	0.00245	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Temozolomide—melanoma	0.00144	0.00243	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dactinomycin—melanoma	0.00138	0.00233	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Temozolomide—melanoma	0.00137	0.00232	CcSEcCtD
Fluocinolone Acetonide—Infection—Dactinomycin—melanoma	0.00137	0.00231	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00135	0.00227	CcSEcCtD
Fluocinolone Acetonide—Cough—Temozolomide—melanoma	0.00133	0.00225	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Temozolomide—melanoma	0.0013	0.0022	CcSEcCtD
Fluocinolone Acetonide—Infestation—Docetaxel—melanoma	0.0013	0.0022	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—melanoma	0.0013	0.0022	CcSEcCtD
Fluocinolone Acetonide—Oedema—Carmustine—melanoma	0.00129	0.00218	CcSEcCtD
Fluocinolone Acetonide—Infection—Carmustine—melanoma	0.00128	0.00216	CcSEcCtD
Fluocinolone Acetonide—Pain—Bleomycin—melanoma	0.00126	0.00213	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00126	0.00212	CcSEcCtD
Fluocinolone Acetonide—Oedema—Temozolomide—melanoma	0.00125	0.00211	CcSEcCtD
Fluocinolone Acetonide—Infection—Temozolomide—melanoma	0.00124	0.00209	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Temozolomide—melanoma	0.00122	0.00206	CcSEcCtD
Fluocinolone Acetonide—Pain—Dactinomycin—melanoma	0.00118	0.00199	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Carmustine—melanoma	0.00118	0.00198	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—melanoma	0.00117	0.00198	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Bleomycin—melanoma	0.00117	0.00197	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—melanoma	0.00115	0.00194	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00114	0.00192	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Docetaxel—melanoma	0.00112	0.0019	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Carmustine—melanoma	0.00111	0.00188	CcSEcCtD
Fluocinolone Acetonide—Pain—Carmustine—melanoma	0.0011	0.00186	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—melanoma	0.00109	0.00184	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dactinomycin—melanoma	0.00109	0.00184	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Bleomycin—melanoma	0.00109	0.00184	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Temozolomide—melanoma	0.00108	0.00182	CcSEcCtD
Fluocinolone Acetonide—Pain—Temozolomide—melanoma	0.00107	0.0018	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—melanoma	0.00105	0.00178	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Bleomycin—melanoma	0.00105	0.00177	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—melanoma	0.00103	0.00174	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—melanoma	0.00102	0.00173	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Carmustine—melanoma	0.00102	0.00172	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—melanoma	0.00102	0.00172	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—melanoma	0.00102	0.00172	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Dactinomycin—melanoma	0.00102	0.00172	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—melanoma	0.000995	0.00168	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Temozolomide—melanoma	0.000986	0.00166	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—melanoma	0.000983	0.00166	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP17A1—melanoma	0.000965	0.177	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Carmustine—melanoma	0.000951	0.00161	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Dactinomycin—melanoma	0.000943	0.00159	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Bleomycin—melanoma	0.00094	0.00159	CcSEcCtD
Fluocinolone Acetonide—Rash—Bleomycin—melanoma	0.000932	0.00157	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Bleomycin—melanoma	0.000931	0.00157	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Temozolomide—melanoma	0.000919	0.00155	CcSEcCtD
Fluocinolone Acetonide—Cough—Docetaxel—melanoma	0.000887	0.0015	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Carmustine—melanoma	0.000883	0.00149	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Temozolomide—melanoma	0.000882	0.00149	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bleomycin—melanoma	0.000878	0.00148	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dactinomycin—melanoma	0.000877	0.00148	CcSEcCtD
Fluocinolone Acetonide—Rash—Dactinomycin—melanoma	0.000869	0.00147	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Docetaxel—melanoma	0.000865	0.00146	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carmustine—melanoma	0.000853	0.00144	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Temozolomide—melanoma	0.000853	0.00144	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—melanoma	0.000829	0.0014	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Temozolomide—melanoma	0.000825	0.00139	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—melanoma	0.000824	0.00139	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Carmustine—melanoma	0.000821	0.00139	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dactinomycin—melanoma	0.000819	0.00138	CcSEcCtD
Fluocinolone Acetonide—Rash—Carmustine—melanoma	0.000814	0.00137	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—melanoma	0.000813	0.00137	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Carmustine—melanoma	0.000813	0.00137	CcSEcCtD
Fluocinolone Acetonide—Headache—Carmustine—melanoma	0.000808	0.00136	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Temozolomide—melanoma	0.000793	0.00134	CcSEcCtD
Fluocinolone Acetonide—Rash—Temozolomide—melanoma	0.000786	0.00133	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NOS2—melanoma	0.000786	0.145	CrCbGaD
Fluocinolone Acetonide—Dermatitis—Temozolomide—melanoma	0.000786	0.00133	CcSEcCtD
Fluocinolone Acetonide—Headache—Temozolomide—melanoma	0.000781	0.00132	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carmustine—melanoma	0.000767	0.00129	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000756	0.00128	CcSEcCtD
Fluocinolone Acetonide—Nausea—Temozolomide—melanoma	0.000741	0.00125	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—melanoma	0.000716	0.00121	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—melanoma	0.000709	0.0012	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1B1—melanoma	0.000669	0.123	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—melanoma	0.000656	0.00111	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—melanoma	0.000611	0.00103	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—melanoma	0.000599	0.11	CrCbGaD
Fluocinolone Acetonide—Pruritus—Docetaxel—melanoma	0.000587	0.000991	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—melanoma	0.000567	0.000958	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Docetaxel—melanoma	0.000548	0.000926	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—melanoma	0.000527	0.00089	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—melanoma	0.000523	0.000883	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—melanoma	0.000522	0.000882	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—melanoma	0.00052	0.000877	CcSEcCtD
Fluocinolone Acetonide—Nausea—Docetaxel—melanoma	0.000493	0.000832	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—melanoma	0.000478	0.0878	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—melanoma	0.000474	0.0871	CrCbGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—melanoma	0.000388	0.0713	CrCbGaD
Fluocinolone Acetonide—Prednisolone—ABCB1—melanoma	0.000337	0.0619	CrCbGaD
Fluocinolone Acetonide—Betamethasone—ABCB1—melanoma	0.00033	0.0606	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000319	0.000794	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—melanoma	0.000319	0.000794	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000315	0.000784	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000315	0.000783	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RHOB—melanoma	0.000314	0.000782	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000307	0.000763	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CB—melanoma	0.000305	0.000759	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000304	0.000756	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ITGB1—melanoma	0.000302	0.000752	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000297	0.000738	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000296	0.000737	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000295	0.000733	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB4—melanoma	0.000295	0.000732	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL1—melanoma	0.000295	0.000732	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—melanoma	0.000293	0.00073	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000293	0.000728	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000292	0.000727	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PHGDH—melanoma	0.000287	0.000714	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LUM—melanoma	0.000287	0.000714	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCR2—melanoma	0.000286	0.000712	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000286	0.000711	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAC2—melanoma	0.000282	0.0007	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HPSE—melanoma	0.000282	0.0007	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000281	0.0007	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IL2—melanoma	0.00028	0.000697	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—WNT5A—melanoma	0.000277	0.000689	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRRAP—melanoma	0.000277	0.000688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CUL3—melanoma	0.000277	0.000688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HGF—melanoma	0.000276	0.000687	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CUBN—melanoma	0.000276	0.000687	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000274	0.000682	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CSF2—melanoma	0.000273	0.00068	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—melanoma	0.000272	0.000675	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—melanoma	0.000271	0.000674	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1B10—melanoma	0.000269	0.00067	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000268	0.000665	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDHD—melanoma	0.000267	0.000664	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CSPG4—melanoma	0.000267	0.000664	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BSG—melanoma	0.000267	0.000664	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000262	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ITGB3—melanoma	0.000262	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCA—melanoma	0.000262	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPAM—melanoma	0.000259	0.000643	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000258	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—melanoma	0.000255	0.000634	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000253	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000253	0.000629	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2RL1—melanoma	0.00025	0.000623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000246	0.000612	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000245	0.00061	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2R—melanoma	0.000243	0.000605	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAC1—melanoma	0.000243	0.000604	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000241	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000241	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00024	0.000597	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS3—melanoma	0.000239	0.000594	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—melanoma	0.000238	0.000592	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000238	0.000591	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDNRB—melanoma	0.000236	0.000586	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM3—melanoma	0.000235	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SKI—melanoma	0.000235	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SNRPE—melanoma	0.000235	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—melanoma	0.000235	0.000584	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CDK2—melanoma	0.000231	0.000574	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000229	0.00057	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000228	0.000566	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—melanoma	0.000226	0.0415	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—melanoma	0.000225	0.00056	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000223	0.000555	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KISS1—melanoma	0.000223	0.000555	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000223	0.000554	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAB2—melanoma	0.000223	0.000554	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNA11—melanoma	0.000223	0.000554	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—melanoma	0.000221	0.000549	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLA2G6—melanoma	0.00022	0.000546	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000218	0.000541	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SKI—melanoma	0.000216	0.000537	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR1—melanoma	0.000216	0.000537	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FN1—melanoma	0.000215	0.000533	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—melanoma	0.000214	0.000533	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MC1R—melanoma	0.000213	0.000529	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—melanoma	0.000212	0.000527	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCR4—melanoma	0.000209	0.000521	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000209	0.00052	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNAQ—melanoma	0.000207	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—melanoma	0.000205	0.00051	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR7—melanoma	0.000204	0.000508	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM1—melanoma	0.000204	0.000508	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EGF—melanoma	0.000203	0.000505	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000202	0.000503	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SUFU—melanoma	0.000199	0.000495	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—VCAN—melanoma	0.000197	0.000491	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCB1—melanoma	0.000192	0.0353	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT3—melanoma	0.000191	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000191	0.000474	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—melanoma	0.000188	0.000467	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000187	0.000465	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—melanoma	0.000186	0.000463	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RHOB—melanoma	0.000186	0.000462	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BCL2L11—melanoma	0.000186	0.000462	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NPPA—melanoma	0.000184	0.000458	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—melanoma	0.00018	0.000449	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00018	0.000448	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC6—melanoma	0.000178	0.000444	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—melanoma	0.000178	0.000443	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—melanoma	0.000178	0.000443	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000171	0.000425	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR2—melanoma	0.000169	0.000421	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP17A1—melanoma	0.000167	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAC2—melanoma	0.000166	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000164	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFC—melanoma	0.000164	0.000407	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—WNT5A—melanoma	0.000164	0.000407	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000162	0.000403	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000161	0.0004	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—melanoma	0.000161	0.000399	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNA11—melanoma	0.000157	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—melanoma	0.000157	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CSF2—melanoma	0.000157	0.00039	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000154	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FASN—melanoma	0.000154	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—melanoma	0.000152	0.000378	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000152	0.000377	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—melanoma	0.000151	0.000376	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCA—melanoma	0.00015	0.000374	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAP2K2—melanoma	0.000147	0.000366	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNAQ—melanoma	0.000146	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD44—melanoma	0.000146	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—melanoma	0.000144	0.000359	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2R—melanoma	0.000144	0.000358	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000143	0.000356	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000142	0.000353	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1B1—melanoma	0.00014	0.000349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAC1—melanoma	0.000139	0.000347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRB—melanoma	0.000139	0.000346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTK2B—melanoma	0.000135	0.000336	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HDAC2—melanoma	0.000135	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAB2—melanoma	0.000132	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNA11—melanoma	0.000132	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FLT1—melanoma	0.000131	0.000326	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000124	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR4—melanoma	0.000124	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC2—melanoma	0.000124	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FOXO4—melanoma	0.000124	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—melanoma	0.000123	0.000305	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNAQ—melanoma	0.000122	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NRAS—melanoma	0.000121	0.000302	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—melanoma	0.000118	0.000293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—melanoma	0.000116	0.000289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—melanoma	0.000115	0.000287	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SYK—melanoma	0.000115	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT3—melanoma	0.000113	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGAV—melanoma	0.000113	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGFR—melanoma	0.000113	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK1—melanoma	0.000111	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—melanoma	0.000108	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PRKCA—melanoma	0.000106	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ERCC2—melanoma	0.000105	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—VDR—melanoma	0.000105	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS1—melanoma	0.000104	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—melanoma	0.000104	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAP2K1—melanoma	0.000104	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—S100B—melanoma	0.000104	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—melanoma	0.000104	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB4—melanoma	9.97e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—melanoma	9.88e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PRKCA—melanoma	9.67e-05	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ERCC2—melanoma	9.59e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—melanoma	9.59e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CD86—melanoma	9.56e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—melanoma	9.48e-05	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—melanoma	9.28e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF1—melanoma	9.27e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CSF2—melanoma	9.27e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F1—melanoma	9.07e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—melanoma	9.03e-05	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFRA—melanoma	8.98e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCA—melanoma	8.89e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGB3—melanoma	8.89e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—melanoma	8.87e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.73e-05	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPP1—melanoma	8.71e-05	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP2K2—melanoma	8.69e-05	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—melanoma	8.68e-05	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—melanoma	8.66e-05	0.000215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—melanoma	8.32e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—melanoma	8.29e-05	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—melanoma	8.26e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAC1—melanoma	8.24e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—melanoma	8.03e-05	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—melanoma	7.9e-05	0.000196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—melanoma	7.83e-05	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—melanoma	7.74e-05	0.000193	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—melanoma	7.56e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—melanoma	7.32e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—melanoma	7.31e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—melanoma	7.27e-05	0.000181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—melanoma	7.22e-05	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—melanoma	7.12e-05	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CD80—melanoma	6.97e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—melanoma	6.96e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—melanoma	6.96e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—melanoma	6.96e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NRAS—melanoma	6.96e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGF—melanoma	6.88e-05	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—melanoma	6.67e-05	0.000166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—melanoma	6.54e-05	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—melanoma	6.38e-05	0.000159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—melanoma	6.37e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK1—melanoma	6.34e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—melanoma	6.34e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—melanoma	6.32e-05	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP2K1—melanoma	6.16e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—melanoma	6.12e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—melanoma	5.99e-05	0.000149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—melanoma	5.86e-05	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—melanoma	5.51e-05	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—melanoma	5.5e-05	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—melanoma	5.48e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—melanoma	5.4e-05	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—melanoma	5.33e-05	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—melanoma	5.12e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—melanoma	5.09e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—melanoma	5e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—melanoma	4.91e-05	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—melanoma	4.9e-05	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—melanoma	4.87e-05	0.000121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—melanoma	4.77e-05	0.000119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—melanoma	4.73e-05	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—melanoma	4.64e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—melanoma	4.62e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—melanoma	4.61e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKB1—melanoma	4.59e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—melanoma	4.5e-05	0.000112	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—melanoma	4.28e-05	0.000107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—melanoma	4.17e-05	0.000104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—melanoma	4.16e-05	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—melanoma	4.12e-05	0.000102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRAS—melanoma	4.11e-05	0.000102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—melanoma	3.94e-05	9.79e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—melanoma	3.89e-05	9.67e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—melanoma	3.83e-05	9.52e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK1—melanoma	3.75e-05	9.31e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—melanoma	3.75e-05	9.31e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—melanoma	3.54e-05	8.8e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—melanoma	3.25e-05	8.08e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—melanoma	3.18e-05	7.9e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—melanoma	3.15e-05	7.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—melanoma	3.01e-05	7.48e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—melanoma	2.89e-05	7.19e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—melanoma	2.88e-05	7.16e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—melanoma	2.66e-05	6.6e-05	CbGpPWpGaD
